[ Content | Sidebar ]


2004 Detox Journal: Practice Recommendation in Alcohol Withdrawal Treatment

October 18th, 2009

Herein you will be provided with detoxification journal regarding alcohol withdrawal treatment. Mostly, individuals algorithm in guiding a patient through alcohol detoxification having for alcohol detoxification perform significant symptoms of alcohol withdrawal. According to many researches and study, it takes up to 71% of individuals presenting this condition.

What you will find in this detoxification journal are sections such physiology of alcohol withdrawal, initial assesment of alcohol withdrawal patients, Assess the severity of the withdrawal, pharmacotherapy to treat their symptoms (benzodiazepin, carbamazepin, and valproic acid), The acceptable medication regimens for treating alcohol withdrawal, and inpatient or outpatient setting.

2004 Detox Journal: Practice Recommendation in Alcohol Withdrawal Treatment continued »

Bookmark and Share

2004 Biochemistry Journal: How Lead Contamination Influence Purin Metabolism Pathways?

October 18th, 2009

Mainly, lead present in blood located in eryhrocytes. Its toxicity comes from the ability to create complexes with the Pathway of purine metabolism in erythrocytes' scheme negatively charged ligands. The following journal will provide you with a review outlines lead distribution (contamination) and its influence on purine conversion pathways in human erythrocites.

Sections describe on this Biochemistry Journal are Role of the Nucleotide Purines in Erythrocyte Metabolism Regulation, Purine Nucleotides Metabolism, Lead Ion Influenced Disorders in the Erythrocyte Energy Metabolism, and Mechanisms of the Toxic Effect of Lead. Also there are several pathway illustration scheme such biological significance of some adenilate containing molecules, The synthesis PRPP in erythrocytes, and Pathway of purine metabolism in erythrocytes (click scheme to enlarge) .

2004 Biochemistry Journal: How Lead Contamination Influence Purin Metabolism Pathways? continued »

Bookmark and Share

Influenza Article: 2009-10 Seasonal Influenza Vaccine Type, Age Group and Dosage

October 17th, 2009

influenza A (H1N1) 2009 monovalent influenza vaccinesThe following article contains informations about 2009-10 Seasonal Influenza Vaccine regarding its types and dosages.  All influenza vaccines available in the United States for the 2009-10 influenza season are produced using embryonated hen’s eggs and contain residual egg protein and also contain no adjuvants, according to the CDC MMWR weekly report.

The age groups, precautions, and contraindications approved for the influenza A (H1N1) 2009 monovalent vaccine are identical to those approved for seasonal vaccines. Influenza A (H1N1) 2009 monovalent vaccine approvals vaccines were made on the basis of standards developed for vaccine strain changes for seasonal influenza vaccines, …

As also stated by the FDA, there are CSL Limited, MedImmune LLC, Novartis Vaccines and Diagnostics Limited, and Sanofi Pasteur Inc which received approval for the influenza vaccine manufacturers. The H1N1 vaccines approved today undergo the same rigorous FDA manufacturing oversight, product quality testing and lot release procedures that apply to seasonal influenza vaccines, said the acting chief scientist of the FDA.

Influenza Article: 2009-10 Seasonal Influenza Vaccine Type, Age Group and Dosage continued »

Bookmark and Share

2004 Hematology Article Guideline: Management of Children Sickle Cell Disease Complication

October 15th, 2009

The following article is a clinical practice guideline that consist of informations about the Management of Sickle Cell Pediatric Hematology Disease in Children. This hematology article guideline is not intended to replace long-term management by a paediatric hematologist, but are focussed at management of children with complications of sickle cell disease.

What you will find in this Sickle Cell Disease Article are sections such as Inclusion Criteria of Paediatric patient presenting to ER, General Recommendations for the Management of Paediatric Sickle Cell Disease, Guidelines for Specific Clinical Settings (vaso-occlusive crisis/VOC, Fever/Rule Out Infection), Antimicrobial Therapy Guidelines, and Acute Chest Syndrome or Pneumonia Management.

2004 Hematology Article Guideline: Management of Children Sickle Cell Disease Complication continued »

Bookmark and Share